7.8% Growth Rate for Clinical Trial Supplies by 2025 | Global Forecast, Trends, Opportunity and Industry Analysis
The “Clinical Trial Supplies Market” report presents an in-depth assessment of the Cryotherapy including key trends, market drivers, challenges, deployment case studies, standardization, opportunities, future roadmap, value chain, Top key player profiles and strategies. The report also presents market size forecasts from 2017 till 2022.
Get Instant Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=427439
The Clinical Trial Supplies Market is projected to reach USD 2.5 Billion by 2025 from USD 1.7 Billion in 2020, at a CAGR of 7.8%.This report spread across 158 Pages, Profiling 10 Companies and Supported with 90 Tables and 74 figures is now available in this research. An exclusive data offered in this report is collected by research and industry experts team.
Top Key Players profiled in the Clinical Trial Supplies market include are Catalent, Inc.(US),Almac Group (UK),Parexel International Corporation (US),Thermo Fisher Scientific, Inc. (US),PCI Services (US),UDG Healthcare Plc. (Ireland),Biocair (UK),Bilcare Limited (India),O&M Movianto (US),KLIFO A/S (Denmark),Capsugel (Switzerland),Infosys Limited (India),PRA Health Sciences, Inc. (US),Eurofins Scientific (Luxembourg),Marken (US),Seveillar Clinical Trial Supplies Pvt. Ltd. (India),N-SIDE (Belgium).
Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of the clinical trial supplies market during the forecast period. This can primarily be attributed to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.
Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. The oncology segment is expected to account for the largest share of the market in 2020 and is estimated to register the highest growth during the forecast period majorly due to the high and growing number of research studies on cancer therapeutics and a large number of companies focusing on bringing innovative cancer drugs to the market.
Coupon Code Available for 20% Discount @ https://www.reportsnreports.com/purchase.aspx?name=427439
“North America will continue to dominate the clinical trial supplies market during the forecast period”
In 2020, North America is estimated to be the largest regional market for clinical trial supplies, followed by Europe. The presence of well-established CROs and the high and growing investments in drug discovery and development by pharmaceutical and biopharmaceutical companies in North America are the major factors responsible for the large share of this region in the global market.
Breakdown of primary participants’ profile:
By Company Type: Tier 1 – 36%, Tier 2 – 45%,and Tier 3 -19% By Designation: C-level – 33%, D-level – 40%, and Others – 27% By Region: North America – 39%, Europe – 30%, Asia Pacific – 22%, and RoW – 9%
Competitive Landscape of Clinical Trial Supplies market:
2 Market Share Analysis, 2018
3 Competitive Scenario
3.1 Service Launches
3.2 Agreements and Collaborations
3.5 Other Developments
4 Competitive Leadership Mapping (2019)
4.1 Vendor Inclusion Criteria
4.2 Visionary Leaders
4.4 Dynamic Differentiators
4.5 Emerging Companies
Reason to access this report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial supplies market and its sub segments.It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies.